Meeting
2022 ASCO Quality Care Symposium
The association between body composition, quality of life (QoL), overall survival (OS) and decision to treat (DTT) in patients with metastatic non–small cell lung cancer (mNSCLC).
Authors
Hyejung Lee
Univeristy of Utah, Salt Lake City, UT
Hyejung Lee, Ben Haaland, Wallace L. Akerley, Adriana M Coletta, Jeffrey T. Yap, Sonam Puri, Kathleen Claire Kerrigan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Decision Support Tools
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 377)
DOI
10.1200/JCO.2022.40.28_suppl.377
Abstract #
377
Poster Bd #
E16
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Using real-world patient experiences to inform point-of-care decisions and care management strategies in urothelial carcinoma.
First Author: Tariqa Ackbarali
Poster
2022 ASCO Annual Meeting
Association of early tumor growth rate and survival outcomes in first-line metastatic non–small cell lung cancer (mNSCLC).
First Author: Antonio Tito Fojo
Poster
2022 ASCO Annual Meeting
Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non–small cell lung cancer (aNSCLC).
First Author: Diego Perez Parente
Poster
2022 ASCO Annual Meeting
Using CT-based body composition metrics and frailty index in predicting survival among older adults with cancer.
First Author: Smith Giri